According to GuruFocus data, the largest Insider Buys this week were for Keurig Dr Pepper Inc. (KDP, Financial), CME Group Inc. (CME, Financial), Allogene Therapeutics Inc. (ALLO, Financial) and Old Republic International Corp. (ORI, Financial).
Keurig Dr Pepper Inc.
President of International and Business Development Mauricio Leyva Arboleda bought 123,400 shares on June 8 at the average price of $28.47. The price of the stock has decreased by 1.23% since.
Keurig Dr Pepper Inc. is an American beverage conglomerate. Its East-coast division sells coffee, beverages and Keurig brewers. The company also sells sodas, juices and other soft drinks from its Dr. Pepper Snapple division in Texas. The company has a market capitalization of $39.57 billion, and as of June 12 it traded at $28.12.
On May 22, Keurig Dr Pepper Inc. announced the completion of its previously announced public secondary offering of 40.0 million shares, or approximately 2.8% of the company’s outstanding common stock. The gross proceeds from the offering totaled approximately $1.08 billion.
CME Group Inc.
Director William R. Shepard bought 1,229 shares on June 11 at the average price of $178.10. The price of the stock has decreased by 1.9% since.
CME Group Inc. is an American international financial services company that is the world’s largest financial derivatives exchange. The company trades in asset classes including agricultural products, currencies, energy, interest rates and stock indexes. The company is also a part of the S&P 500. The company has a market capitalization of $62.65 billion, and as of June 12 it traded at $174.72.
On April 29, CME Group Inc. reported financial results for the first quarter of 2020. Revenue for the quarter was $1.5 billion, while operating income was $960 million, net income totaled $766 million and diluted earnings per share were $2.14. As of March 31, the company had approximately $1.0 billion in cash and $3.5 billion in debt.
Allogene Therapeutics Inc.
Director Arie Belldegrun bought 146,382 shares on June 4 at the average price of $47. The price of the stock has decreased by 13.85% since.
Allogene Therapeutics Inc. is an American clinical-stage biotechnology company that focuses on the development of allogeneic chimeric receptor T cell therapies for cancer. The company is developing a pipeline of therapy candidates with the goal of delivering therapies more reliability and at a greater scale to more patients. The company has a market capitalization of $5.62 billion, and as of June 12 it traded at $40.49.
On June 1, Allogene Therapeutics Inc. announced the pricing of an underwritten public offering of 11,702,128 shares of its common stock at a price of $47.00 per share to the public. The proceeds from the offering are expected to be approximately $550 million. The offering closed on June 4 and the company has granted the underwriters a 30-day option to purchase up to an additional 1,755,319 shares of its common stock at the public offering price.
Old Republic International Corp
Director Aldo C. Zucaro bought 5,000 shares of on June 11 at the average price of $16.00. The price of the stock has increased by 2.69% since.
Old Republic International Corp. is an American insurance holding company whose subsidiaries provide risk management services for a wide variety of coverages, focusing in the general and title insurance fields. The company is listed as part of the Fortune 500 and its title insurance operations are the third largest in the industry. The company has a market capitalization of $4.99 billion, and as of June 12 it traded at $16.43.
On May 7, Old Republic International Corp. announced that the company’s Board of Directors has declared a quarterly cash dividend of $0.21 on the company’s common stock. The dividend will be payable on June 15 to shareholders of record at the close of business on June 5.
For the complete list of stocks that were bought by their company executives, go to: Insider Trades.
Disclosure: I do not own stock in any of the companies mentioned in the article.
Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here
